Derek Bos1, Shawn Dason1, Edward Matsumoto1, Jehonathan Pinthus1, Christopher Allard2. 1. McMaster University, Hamilton, ON, Canada. 2. McMaster University, Hamilton, ON, Canada;; Massachusetts General Hospital, Boston, MA, United States;; Brigham and Women's Hospital, Boston, MA, United States.
Abstract
INTRODUCTION: Our aim was to evaluate whether obesometric serum hormones and body fat distribution are associated with renal stone recurrence. METHODS: We conducted a prospective cohort study of participants undergoing renal stone (RS) intervention at a single institution from November 2009-June 2010 and followed them for a median 62 months. Obesometric parameters were measured at baseline, including body mass index (BMI), fasting serum leptin and adiponectin, and proportion of visceral adipose tissue (%VAT) averaged from three fixed axial computed tomography (CT) slices. The primary study outcome was stone recurrence. RESULTS: A total of 110 participants were enrolled. Elevated %VAT was associated RS recurrence; participants with %VAT in the highest quartile had a five-year stone-free rate of 47.1% compared to 72.2% among other participants (p=0.004). Adjusting for gender, elevated %VAT was independently predictive of renal stone recurrence among initial stone formers (n=74; hazard ratio [HR] 4.53, 95% confidence interval [CI] 1.08-19.02), but not among recurrent stone formers (n=19; HR 0.51, 95% CI 0.054-4.72). Other obesometric factors, including leptin, adiponectin, and BMI, were not significantly predictive of recurrence. CONCLUSIONS: We report a novel association between an elevated %VAT and stone recurrence. These findings may inform patient counselling and followup regimens. The metabolic basis for these findings requires further investigation.
INTRODUCTION: Our aim was to evaluate whether obesometric serum hormones and body fat distribution are associated with renal stone recurrence. METHODS: We conducted a prospective cohort study of participants undergoing renal stone (RS) intervention at a single institution from November 2009-June 2010 and followed them for a median 62 months. Obesometric parameters were measured at baseline, including body mass index (BMI), fasting serum leptin and adiponectin, and proportion of visceral adipose tissue (%VAT) averaged from three fixed axial computed tomography (CT) slices. The primary study outcome was stone recurrence. RESULTS: A total of 110 participants were enrolled. Elevated %VAT was associated RS recurrence; participants with %VAT in the highest quartile had a five-year stone-free rate of 47.1% compared to 72.2% among other participants (p=0.004). Adjusting for gender, elevated %VAT was independently predictive of renal stone recurrence among initial stone formers (n=74; hazard ratio [HR] 4.53, 95% confidence interval [CI] 1.08-19.02), but not among recurrent stone formers (n=19; HR 0.51, 95% CI 0.054-4.72). Other obesometric factors, including leptin, adiponectin, and BMI, were not significantly predictive of recurrence. CONCLUSIONS: We report a novel association between an elevated %VAT and stone recurrence. These findings may inform patient counselling and followup regimens. The metabolic basis for these findings requires further investigation.
Authors: Jennifer L Kuk; Peter T Katzmarzyk; Milton Z Nichaman; Timothy S Church; Steven N Blair; Robert Ross Journal: Obesity (Silver Spring) Date: 2006-02 Impact factor: 5.002
Authors: Caroline S Fox; Shih-Jen Hwang; Joseph M Massaro; Kathrin Lieb; Ramachandran S Vasan; Christopher J O'Donnell; Udo Hoffmann Journal: Am J Cardiol Date: 2009-06-24 Impact factor: 2.778
Authors: Kathryn A Britton; Joseph M Massaro; Joanne M Murabito; Bernard E Kreger; Udo Hoffmann; Caroline S Fox Journal: J Am Coll Cardiol Date: 2013-07-10 Impact factor: 24.094
Authors: Grazina Urbonaviciene; Jan Frystyk; Allan Flyvbjerg; Eskild W Henneberg; Jes S Lindholt Journal: Atherosclerosis Date: 2010-01-04 Impact factor: 5.162
Authors: Zixing Ye; He Xiao; Guanghua Liu; Yi Qiao; Yi Zhao; Zhigang Ji; Xiaohong Fan; Rongrong Li; Ou Wang Journal: Front Endocrinol (Lausanne) Date: 2022-06-30 Impact factor: 6.055